Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A 73-year-old man's grey-white hair turned dark brown after eczema treatment.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

A thorough history and examination are crucial for diagnosing skin diseases, which affect up to a third of people. This includes details about skin lesions, medication, general health, lifestyle, family, and contacts, as well as examining the rash, hair, nails, and mucous membranes. Changes in hair and nails can also indicate other medical and skin disorders.

Testosterone therapy can improve skin and hair in men with low testosterone but may cause skin irritation with certain treatments.

Treatments for hair loss include estrogen therapy and special shampoos.

Female hair loss patients more likely to have dry eye and gland issues.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Keloids may be influenced by stress and psychological factors.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

The conclusion is that a systematic approach is key for treating symmetrical alopecia in dogs, but treatment may not always be necessary.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Hair aging leads to color loss and reduced density, and dermatologists are key in treating it to improve quality of life.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Dermatologists need to understand African American hair-care practices to better treat their hair and scalp disorders.

Mice with human skin protein K8 had more skin problems and cancer.

The conclusion is that understanding how feathers and hairs pattern can help in developing hair regeneration treatments.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.